Trademark: 88143118
Word
INPERNUM PHARMA CONSULTING
Status Date
Wednesday, October 9, 2019
Filing Date
Thursday, October 4, 2018
Abandoned Date
Monday, September 16, 2019
42 Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Technical consulting in the field of pharmaceutical studies
The color(s) blue and orange is/are claimed as a feature of the mark.
"PHARMA CONSULTING"
The mark consists of the stylized blue wording "INPERNUM PHARMA CONSULTING" with an orange split dot over the letter "I" in "INPERNUM". The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Oct 9, 2019
Abandonment Notice E-Mailed - Failure To Respond
Oct 9, 2019
Abandonment - Failure To Respond Or Late Response
Mar 13, 2019
Notification Of Final Refusal Emailed
Mar 13, 2019
Final Refusal E-Mailed
Mar 13, 2019
Final Refusal Written
Mar 8, 2019
Teas/Email Correspondence Entered
Mar 8, 2019
Correspondence Received In Law Office
Mar 7, 2019
Assigned To Lie
Mar 4, 2019
Teas Response To Office Action Received
Jan 22, 2019
Notification Of Examiner's Amendment/Priority Action E-Mailed
Jan 22, 2019
Examiner's Amendment/Priority Action E-Mailed
Jan 22, 2019
Combined Examiner's Amendment/Priority Action Automatic Entry
Jan 22, 2019
Examiners Amendment And/Or Priority Action - Completed
Jan 16, 2019
Assigned To Examiner
Oct 16, 2018
Notice Of Design Search Code E-Mailed
Oct 13, 2018
New Application Office Supplied Data Entered In Tram
Oct 8, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
